Management of Pregnant Woman with Cough, Cold, and Fever
A pregnant woman presenting with cough, nasal congestion, and fever should receive immediate empiric antiviral treatment with oseltamivir if influenza is suspected, along with safe symptomatic management using saline nasal rinses, topical nasal corticosteroids (budesonide, fluticasone, or mometasone), and penicillin or cephalosporin antibiotics only if bacterial sinusitis with purulence is confirmed.
Initial Assessment and Risk Stratification
The presence of fever with respiratory symptoms in pregnancy requires urgent evaluation because pregnant women are at high risk for serious complications from influenza, which carries significant maternal morbidity and mortality 1. You must distinguish between:
- Influenza (fever + cough ± systemic symptoms)
- Acute bacterial rhinosinusitis (purulent discharge, facial pain/pressure)
- Viral upper respiratory infection (common cold)
- COVID-19 (if epidemiologically relevant)
Key red flags requiring immediate hospitalization: Shortness of breath, chest pain, persistent high fever, or inability to maintain hydration 2. Women presenting with fever, cough, shortness of breath, chest pain, or nausea/vomiting are more likely to require admission 2.
Treatment Algorithm
If Influenza is Suspected (Fever + Cough):
Start oseltamivir immediately based on clinical presentation—do not wait for laboratory confirmation 1. Treatment is necessary for all pregnant women with suspected or confirmed influenza, regardless of vaccination status. While ideally started within 48 hours of symptom onset, do not withhold treatment if this window is missed 1. The high potential for maternal morbidity and mortality justifies presumptive treatment 1.
For Nasal Congestion and Rhinitis Symptoms:
First-line therapy:
- Saline nasal rinses - safe and effective 3
- Topical nasal corticosteroids (budesonide, fluticasone, or mometasone at recommended doses) - all modern nasal corticosteroids are safe during pregnancy 3
Avoid completely:
- Oral decongestants - increase risk of fetal gastroschisis and maternal hypertension 3
- First-generation antihistamines - sedative and anticholinergic properties make them unsuitable 3
Second-generation antihistamines (loratadine or cetirizine) can be considered if allergic rhinitis is suspected, as they are generally safe 4.
For Suspected Bacterial Sinusitis:
Only prescribe antibiotics if there is endoscopic or clinical evidence of purulence 3. When indicated:
Safe options:
- Penicillins (first choice)
- Cephalosporins (first choice)
Absolutely contraindicated:
- Tetracyclines
- Aminoglycosides
- Trimethoprim-sulfamethoxazole
- Fluoroquinolones
- Long-term macrolides or doxycycline 3
For Fever Management:
Acetaminophen is the preferred antipyretic in pregnancy. Avoid NSAIDs, particularly in the third trimester.
Monitoring Strategy
For mild-to-moderate illness without red flags, intensive outpatient management with systematic telehealth follow-up is appropriate 2. This approach:
- Reduces disease spread to other pregnant patients
- Allows for virtual prenatal care
- Enables rapid escalation to in-person evaluation if symptoms worsen
95% of patients requiring acute care can be identified through telehealth symptom monitoring 2.
Critical Pitfalls to Avoid
- Delaying antiviral treatment while awaiting influenza testing - treat presumptively based on clinical suspicion 1
- Prescribing oral decongestants - these carry teratogenic risks including cardiac and limb abnormalities 3
- Using antibiotics without evidence of bacterial infection - reserve for confirmed purulent sinusitis only 3
- Underestimating disease severity - pregnancy itself is a high-risk condition for respiratory infections 1, 5
Special Considerations
The median duration to viral clearance can be prolonged (26 days for COVID-19) 2, so extended symptom duration alone does not necessarily indicate treatment failure or bacterial superinfection. Disease progression and symptom duration do not vary significantly by trimester 2.
Maternal hypoxia from undertreated respiratory illness poses well-documented adverse fetal effects, making aggressive maternal treatment the priority 6.